<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://drsvenkatesan.com/2026/07/11/the-tough-task-of-reversing-cardiac-amyloidosis-classification-of-anti-amyloiddrugs/</loc><news:news><news:publication><news:name>Dr.S.Venkatesan MD</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-11T04:44:19+00:00</news:publication_date><news:title>The tough task of reversing cardiac Amyloidosis : Classification of  &#8220;Anti-Amyloid&#8221;drugs</news:title><news:keywords>restrictive cardiomyopathy, amyloidosis, cardiac amyloidosis, attr amyloid, congored, pyrophosphate scan for amyloid, classification of anti amyloid drugs, tafamidis, onpatttro, ttr stabilizers, ttr silencers, doxycycline for amyloidosis, coramitug, amvuttra, tegsedi, wainua, acoramidia, best review article on amyloidosis</news:keywords></news:news></url></urlset>
